Part of the Nanotechnology Commons
Combination Therapy: PARP Inhibitor Synergizes the Therapeutic Efficacy of Doxorubicin in the treatment of Prostate Cancer, Momin Ansare Electronic Theses & Dissertations
PDF
Advanced Search